INTRODUCTION
and papillomatosis are difficult to diagnose by imaging modalities and the role of breast MRI in diagnosis of mammary lesions has increased. 2, 7, 8 Therefore, the purpose of this study was to elucidate the role of 3D dynamic contrast enhanced MRI in the diagnosis and preoperative evaluation of breast papillomas.
Patients
The institutional review board approved this study and required neither patients' approval nor patients' informed consent for review of their images and records. From 1996 to 2004, 94 patients were diagnosed with papillomas of the breast at our institute. Among them, 21 patients had taken 3D fast low angle shot (FLASH) dynamic breast MRI and those patients were enrolled in this study. All patients were female, and their age was 27 to 74 years (mean age: 46.3 years). Eleven of 21 patients had nipple discharge, and 2 patients among them showed palpable masses. Eight masses were palpable and 4 patients were asymptomatic. Three patients were diagnosed with breast cancer and took breast MRI for cancer staging, and another 3 patients took MRI for screening of high risk patients. Inferior portion of the mass showed dilated duct (arrow in Fig. 1B-1 ). The sonographic BI-RADS was category 4a, therefore, US-guided core biopsy was recommend. (C) Dynamic contrast breast MRI subtraction 1 minute (1), 3 minutes (2), 5 minutes (3) images. The mass showed lobulated shape, and smooth margin with rim enhancement. Peritumoral delayed enhancement was noted. The kinetics showed persistent enhancement pattern (4) . We concluded BI-RADS category 3. The core biopsy and excision were done, and pathologic result was intraductal papilloma.
graphy was available in 17 patients, and 17 patients took breast ultrasonography (US), and 8 underwent galactography.
MR imaging
MRI was performed using a 1.5-T magnet (Magnetom Avanto, Siemens Medical Solution, Erlangen, Germany) with a dedicated bilateral breast surface coil with prone position. The imaging protocol and parameters were as follows: axial T1-weighted image (TR/TE, 500/11) and T2-weighted turbo spin-echo image (5000/100) of both breasts were obtained with 3 mm slice thickness. Next, T1-weighted images were acquired using a 3D FLASH (fast low-angle shot pulse sequence) with a fat-selective inversion for fat suppression through both breasts (TR/TE 3.91/1.42, flip angle 30 O ). Precontrast images were obtained over a 512 ×317 matrix in the axial plane with a slice thickness of 1.5 mm without gap before administration of the contrast agent. Then, contrast-enhanced dynamic imaging was performed with an injection of 20 mL of gadopentetate dimeglumine (Magnevist, Berlex Laboratories, Wayne, NJ, USA); five sequential contrast-enhanced images were aquired at every 1 min. The precontrast images were then subtracted from the corresponding postcontrast images on a pixel-by-pixel basis with use of the standard software subtraction function available on our console.
MRI examinations were retrospectively reviewed by two radiologists who experienced in the interpretation of breast MRI examinations.
Two radiologists independently analyzed the location, size of lesions, shape, margin of masses, multiplicity and ductal relation. The MRI findings were described according to ACR BI-RADS lexicon and categorized. The amount and pattern of enhancement and associated findings were also evaluated. We compared the MRI findings with galactography, mammography and breast US and examined histopathologic correlation. The US-guided core biopsy was performed using 14G automated guns (Bard-Magnum 
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Biopsy Instruments, Covington, GA, USA). At least three good cores of tissue were obtained for each lesion. BI-RADS category on mammography, sonography, MRI and MRI kinetics were correlated with pathologic findings and nipple discharge. All statistical analysis was performed using SPSS version 11.0 software. All results with a p value of less than 0.05 were considered significant.
On breast MRI, the lesion size was 0.4 to 4.25 cm (mean 1.54 ± 1.59). On dynamic enhanced images, imaging findings included mass (n = 10), intracystic mass (n = 3), focus (n = 5), ductal enhancement (n = 2), and segmental enhancement (n = 1). In case of the masses, the shapes of the masses were round (n = 4), lobulated (n = 3), and irregular (n = 6) and margins were circumscribed (n = 6), microlobulated (n = 5), and indistinct (n = 2). The enhancement patterns of the mass and intracystic mass were homogeneous enhancement (n = 7), heterogeneous (n = 3) or rim enhancement (n = 3). Four cases among mass enhancement had multiple lesions which showed multiple nodular enhancements. Their pathology of those multiple enhanced nodules was papillomas (n = 2), intraductal papilloma with atypical lobular hyperplasia (n = 1) and papillomatsis (n = 1).
In terms of non-mass like enhancement, 2 cases showed ductal enhancement and 1 case revealed segmental enhancement. Two cases of ductal enhancement revealed 1 intraductal papilloma and 1 papillomatosis, while segmental (4), therefore, the BI-RADS category was 3. The pathologic result after excision was intraductal papilloma.
enhanced lesion was papillomatosis. Those 2 cases of ductal enhancement indicated negative findings in US. After taken breast MRI, the treatment plans for papillary lesions were changed in 5 patients. The kinetic curve of initial phase showed fast enhancement in all cases, and persistent (n = 15), plateau (n = 5), and wash out pattern (n = 1) in delayed phase. In terms of MR kinetics, the lesions with persistent enhancement pattern (n = 15) revealed intraductal papilloma in 12 cases (80%), 1 papillomas, 1 intraductal papilloma with microcalcifications and 1 papillomatosis with microcalcifications. Otherwise, the lesions with plateau pattern enhancement showed 2 intraductal papilloma, 2 papillomatosis and 1 intraductal papiloma with atypical lobular hyperplasia. Overall, BI-RADS categories of breast MRI were 3 (n = 14), 4a (n = 6), and category 4b (n = 1). Among the 14 lesions diagnosed with BI-RADS 3, their final pathologies were: intraductal papilloma (n = 12, 85.7%), papillomas (n = 1) and papillomatosis with microcalcifications (n=1). On BI-RADS, category 4a lesions were: intraductal papilloma (n = 3), papillomatosis (n = 2) and intraductal papilloma with atypical lobular hyperplasia (n = 1). On pathologic evaluations, the lesion size was 0.3 to 3.83 cm, suggesting mild overestimation of lesion size in MRI study. Mammography was performed on 17 cases, and the findings were: negative (n = 4), mass (n = 6), asymmetric density (n = 4), and microcalcifications (n = 3). The mass density revealed well-defined high density mass (n = 6), multiple nodular densities (n = 1), and speculated irregular shaped mass (n = 1). The BI-RADS category of mammography was category 1 (n = 4), 3 (n = 4), 4a (n = 1), 4b (n = 2) and 0 (n=6).
On breast ultrasonography (n = 17), the findings were: mass (n = 11), duct dilatation (n = 3), ill-defined heterogeneous echo (n = 1), and negative findings (n = 2). The mass lesion showed solid (n = 8) or intracystic mass (n = 3), and 3 cases among them showed multiple masses. US BI-RADS categories were category 1 (n = 2), 3 (n = 9), 4a (n = 3), and 4b (n = 3).
On galactography, the findings were: single filling defect (n = 4) and multiple filling defects (n = 4).
US-guided core biopsy was performed when possible (n 1  60  Bloody  3  3  +  3  1  IDP  2  74  -3  3  3  1  Papillomas  3  47  Bloody  1  3  ++  4a  2  Papillomastosis  4  42  Serous  +  3  3  4a  2  IDP with ALH  5  32  -+  3  ++  3  1  IDP  6  50  Serous  3  1  IDP  7  42  Bloody  1  4a  2  IDP  8  49  Bloody  3  1  IDP  9  51  -1  3  3  1  IDP   10  51  -+  4a  4a  4a  2  Papillomatosis  with microca  11  47  Bloody  3  3  +  3  1  IDP  12  59  -+  0  4a  3  1  IDP  13  48  -0  3  +  3  1  IDP  14  40  -+  4b  4b  4a  1  IDP with microca  15  41  -+  0  3  3  1  IDP   16  27  -+  4b  4b  3  1  Papillomatosis  with microca  17  35  Bloody  0  4b  ++  4b  3  IDP  18  39  Bloody  +  0  4a  ++  3  1  IDP  19  46  Serous  1  1  3  1  IDP  20  43  Serous  0  +  3  1  IDP  21  50  -1  4a  2  IDP = 7) , and another surgical biopsies such as mammo-guided (n = 2) or US-guided (n = 5) localization excision were done. In case of MR showing only lesion with persistent nipple discharge, intraoperative ductography guided (n = 4) excision were performed. According to statistical analysis, the nipple discharge was not correlated with BI-RADS of imaging modalities and breast MRI kinetics (p > .05) The imaging findings and BI-RADS categories are listed in Table 1. Breast papillomas are a variety of lesions in the breast that are characterized by a papillary configuration on gross or microscopic examination. These include solitary intraductal papillomas, multiple papillomas, papillomatosis, and juvenile papillomatosis. 1 Solitary intraductal papillomas are tumors of major lactiferous ducts, common cause of a serous or serosanguinous nipple discharge. Papilloma is the most common pathologic finding in women with pathologic nipple discharge, accounting for 40% to 70% of cases. 9 Multiple intraductal papillomas tend to occur in younger patients, are less often associated with nipple discharge, more frequently peripheral and more often bilateral. Essentially, these lesions appear to be susceptible to the development of carcinoma. 10 Carter, et al. 11 reported that 2 of 6 patients with multiple papillomas developed cancer, while only 4 of 58 patients with solitary papilloma developed cancer. Another report found that 5 of 51 patients with multiple papillomas developed cancer, which is in marked contrast to 4 of 174 developed cancers with a solitary papilloma. In this series, 32% of simultaneous or subsequent cancers with multiple papillomas were apocrine papillary and cribriform types. 12 Papillomatosis is a term used to describe microscopic foci of intraductal hyperplasia, which have papillary architecture without atypia. 13 The imaging findings of breast papillomas are very variable, and its pathology is also difficult to diagnose. Breast papillomas are one of the most difficult diagnostic and therapeutic problems, and they could be histologically benign, borderline, or malignant.
On conventional mammography, intraductal papilloma could not be detected, and it has a postitive predictive value of only 25%. The sensitivity is particularly low in young women who have dense breast.
14 In our cases, the mammographic findings were negative in 4 cases. We could detect positive mammographic findings in 13 cases among 17 patients: it is because it was diagnostic setting, therefore, the sensitivity was higher than screening setting. In case of microcalcifications, the morphology and distribution revealed suspicious findings. Therefore, so even if other imaging modality showed probable benign findings, further investigations were required.
The galactography is a traditional method for evaluation of the affected duct system in patients with nipple discharge. It is painful and invasive method, and has some complications which include perforation of duct, extravasations of contrast material, and mastitis. These days, therefore, the galactography was replaced by ultrasonography in most of breast centers. Breast papillomas can be demonstrated by filling defects within the dilated duct on galactography. Distortion, narrowing or obstruction of the ducts may indicate malignancy. 1 We had 8 cases of galactography in breast papillomas, which showed filling defects or narrowing of duct. However, galactography is a painful procedure and has difficulties in differential diagnosis of benign versus malignancy.
Recently, high resolution ultrasonography is helpful in visualizing intraductal disorders and is becoming a method complementary to traditional radiology techniques. 15 However, the sonographic findings of papillomas are variable, and a recent study revealed that sonography is not able to predict malignancy and its positive predictive value is 75%. In our study, the sonographic diagnoses were diverse, and US BI-RADS were 3 to 4b. If patients have nipple discharge or if there was duct dilatation adjacent to the nodules, those findings could possibly have made us to diagnose papillomas. Even more, the ultrasound-guided percutaneous core biopsy and vacuum-assisted large needle biopsy are reliable diagnostic and minimally invasive therapeutic modalities for breast papillomas.
Although MRI is a highly sensitive method for diagnosing breast cancer, its role in the management of papillomas is still controversial. 7, 8 According to Kramer, et al., 7 combination of breast MRI and galactography could not increase the sensitivity, however, MRI could detect the DCIS which escaped detection with galactography. Daniel, et al., divided the MRI findings of papillomas into 3 groups: 1) small luminal mass papillomas, 2) tumor-like papillomas and 3) MRI-occult papillomas. 8 Three groups showed different MRI findings and kinetics. In our cases, there was no case of MRI-occult papilloma. Therefore, the sensitivity of breast MRI of papillomas was 100%. In terms of mass enhancement, the MRI findings were variable. Six masses showed irregular shape enhancement and 13 masses revealed lobulated shape. Therefore, 6 masses among them were MRI BI-RADS category 4a, and 1 was BI-RADS 4b. In our results, there were more papillomatosis or high risk lesions in MRI BI-RADS category 4a than category 3 lesions. If the lesion showed suspicious findings in other imaging modalities, however, the MRI kinetics of the masses showed persistent delayed enhancement, thus making us to consider the possibility of benign mass. There Diagnostic Value of 3D FLASH Dynamic MRI of Breast Papillomas
